3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
185
Neoplasms
111
Breast Neoplasms
100
Colorectal Neoplasms
90
Ovarian Neoplasms
72
Neoplasm Metastasis
70
Prostatic Neoplasms
67
Multiple Myeloma
63
Lung Neoplasms
59
Squamous Cell Carcinoma of Head and Neck
47
Endometrial Neoplasms
46
Recurrence
45
Pancreatic Neoplasms
43
Leukemia, Lymphocytic, Chronic, B-Cell
38
Small Cell Lung Carcinoma
37
Stomach Neoplasms
36
Carcinoma, Renal Cell
36
Melanoma
33
Leukemia, Myeloid, Acute
32
Urinary Bladder Neoplasms
28
Triple Negative Breast Neoplasms
28
Lymphoma, Non-Hodgkin
27
Parkinson Disease 4, Autosomal Dominant Lewy Body
26
Head and Neck Neoplasms
25
Lymphoma, Follicular
24
Carcinoma, Hepatocellular
24
Lymphoma, Large B-Cell, Diffuse
23
Esophageal Neoplasms
22
Advanced Solid Tumors
22
Lymphoma
21
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts